Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2611-2620 of 2760 for cancer

Edit search filters
  1. Human Blood and Tissues Repository for Neuroscience Research

    Jacksonville, FL

  2. The STAR Tumor Ablation Registry

    Rochester, MN

  3. A Study of the Possible Use of a New Imaging Method with Glioma Tumors

    Rochester, MN

  4. A Study of Immune System Activity Cycles in Patients with Surgically Removed Early Stage Melanoma

    Rochester, MN

  5. A Study to Evaluate Skin Angiosarcoma Imaging with Ultrasound

    Rochester, MN

  6. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls

    Rochester, MN

  8. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders

    Jacksonville, FL

  9. A Study of BI-RADS 4 and 5 Lesions that are Malignant and Increased Stiffness on MR Elastography Compared to Lesions that are Benign

  10. Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing Surgery

    Rochester, MN

.

Mayo Clinic Footer